DSM Pharma Chemicals (DPC) has entered into an R&D agreement with the German company IEP to discover and develop biocatalytic solutions designed to simplify and lower the cost of a variety of chemical transformations. Under the terms of the agreement, DSM will identify the targeted chemical conversions and IEP will screen for the appropriate biocatalyst. DSM will then scale-up these processes to manufacture pharmaceutical intermediates and active ingredients. IEP will receive research and de...